trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Carcinoma D002277 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Brain Neoplasms D001932 15 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Melanoma D008545 69 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Stroke D020521 32 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Nerve Degeneration D009410 53 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Nasal Polyps D009298 26 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Translocation, Genetic D014178 20 associated lipids
Cardiomegaly D006332 31 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Radiation Injuries D011832 14 associated lipids
Leishmaniasis D007896 19 associated lipids
Enteritis D004751 8 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Chondrosarcoma D002813 9 associated lipids
Osteomalacia D010018 5 associated lipids
Glioblastoma D005909 27 associated lipids
Keloid D007627 12 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Medulloblastoma D008527 22 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Cat Diseases D002371 12 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Retinoblastoma D012175 12 associated lipids
Genomic Instability D042822 7 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Mastocytoma D034801 3 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Progeria D011371 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Dong X et al. Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells. 2011 Endocr. Relat. Cancer pmid:21367844
Wang QS et al. [Silence mechanism of WT1 gene in leukemic cell line U937]. 2011 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:22040952
Robers MB et al. Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technology. 2011 Mol Biosyst pmid:20931131
Hsu YF et al. MAPK phosphatase-1 contributes to trichostatin A inhibition of cyclooxygenase-2 expression in human umbilical vascular endothelial cells exposed to lipopolysaccharide. 2011 Biochim. Biophys. Acta pmid:21911040
Erb TM et al. Paracrine and epigenetic control of trophectoderm differentiation from human embryonic stem cells: the role of bone morphogenic protein 4 and histone deacetylases. 2011 Stem Cells Dev. pmid:21204619
Salvi V et al. Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 2010 Sep-Oct Immunobiology pmid:20573419
Schuhmann NK et al. Gene transfer into human cord blood-derived CD34(+) cells by adeno-associated viral vectors. 2010 Exp. Hematol. pmid:20447441
Zhang D et al. [Effects of trichostatin A on human lung cancer cell strains A549]. 2010 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:20450546
Ju ZH et al. [Effects of 5-Aza-2'-deoxycitydine and trichostatin A on expression and apoptosis of ALDH1a2 gene in human bladder cancer cell lines]. 2010 Zhonghua Wai Ke Za Zhi pmid:20450613
Lu L et al. Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. 2010 J. Immunol. pmid:20304828
Hizume K et al. Nano-scale analyses of the chromatin decompaction induced by histone acetylation. 2010 Arch. Histol. Cytol. pmid:22572182
Tokési N et al. TPPP/p25 promotes tubulin acetylation by inhibiting histone deacetylase 6. 2010 J. Biol. Chem. pmid:20308065
Tian F et al. Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons. 2010 Ann. N. Y. Acad. Sci. pmid:20633124
Rössler R et al. Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons. 2010 Neuroscience pmid:20643196
Rahman R et al. Histone deacetylase inhibition attenuates cell growth with associated telomerase inhibition in high-grade childhood brain tumor cells. 2010 Mol. Cancer Ther. pmid:20643785
Tong JH et al. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. 2010 BMC Cancer pmid:20525238
Han DS et al. Transcription activation of myostatin by trichostatin A in differentiated C2C12 myocytes via ASK1-MKK3/4/6-JNK and p38 mitogen-activated protein kinase pathways. 2010 J. Cell. Biochem. pmid:20568119
Trtkova K et al. Binding of AR to SMRT/N-CoR complex and its co-operation with PSA promoter in prostate cancer cells treated with natural histone deacetylase inhibitor NaB. 2010 Neoplasma pmid:20568894
Legartova S et al. Expression of RAN, ZHX-2, and CHC1L genes in multiple myeloma patients and in myeloma cell lines treated with HDAC and Dnmts inhibitors. 2010 Neoplasma pmid:20568903
Kim J et al. PS-341 and histone deacetylase inhibitor synergistically induce apoptosis in head and neck squamous cell carcinoma cells. 2010 Mol. Cancer Ther. pmid:20571067
Obier N and Müller AM Chromatin flow cytometry identifies changes in epigenetic cell states. 2010 Cells Tissues Organs (Print) pmid:19776550
Fan J et al. Expression and function of CD9 in melanoma cells. 2010 Mol. Carcinog. pmid:19777564
Xue K et al. Synchronous behaviors of CBP and acetylations of lysine 18 and lysine 23 on histone H3 during porcine oocyte first meiotic division. 2010 Mol. Reprod. Dev. pmid:20575085
Alamdari N et al. Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle. 2010 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:20538901
Li J et al. Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells. 2010 Autophagy pmid:20543569
Vamadevan AS et al. Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis. 2010 Innate Immun pmid:19710105
Suh HS et al. Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes. 2010 J Neuroimmune Pharmacol pmid:20157787
Crosson CE et al. Inhibition of histone deacetylase protects the retina from ischemic injury. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20164449
Jang ER et al. ATM modulates transcription in response to histone deacetylase inhibition as part of its DNA damage response. 2010 Exp. Mol. Med. pmid:20164679
Desai D et al. SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors. 2010 Bioorg. Med. Chem. Lett. pmid:20167479
Ishimaru N et al. Differential epigenetic regulation of BDNF and NT-3 genes by trichostatin A and 5-aza-2'-deoxycytidine in Neuro-2a cells. 2010 Biochem. Biophys. Res. Commun. pmid:20188708
Popova AP et al. Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. 2010 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:20190033
Calonge TM et al. Transformation/transcription domain-associated protein (TRRAP)-mediated regulation of Wee1. 2010 Genetics pmid:20194963
Fakhry H et al. Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells. 2010 Hum. Pathol. pmid:20178884
Wood JP et al. A comparison of differentiation protocols for RGC-5 cells. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20181845
Das ZC et al. Lyophilized somatic cells direct embryonic development after whole cell intracytoplasmic injection into pig oocytes. 2010 Cryobiology pmid:20691649
Mercer TR et al. Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. 2010 BMC Neurosci pmid:20137068
Heier CR et al. Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. 2010 Hum. Mol. Genet. pmid:20693262
Hodges SJ et al. The effect of epigenetic therapy on congenital neurogenic bladders--a pilot study. 2010 Urology pmid:20138341
Bradner JE et al. Chemical phylogenetics of histone deacetylases. 2010 Nat. Chem. Biol. pmid:20139990
Gay S et al. Nucleotide supply, not local histone acetylation, sets replication origin usage in transcribed regions. 2010 EMBO Rep. pmid:20671737
Okada T et al. TWIST1 hypermethylation is observed frequently in colorectal tumors and its overexpression is associated with unfavorable outcomes in patients with colorectal cancer. 2010 Genes Chromosomes Cancer pmid:20140954
Shahabi S et al. Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells. 2010 Gynecol. Oncol. pmid:20674962
Wessels I et al. Changes in chromatin structure and methylation of the human interleukin-1beta gene during monopoiesis. 2010 Immunology pmid:20141541
Zhang C et al. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. 2010 J. Hepatol. pmid:20675009
Choi YS et al. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. 2010 J. Cell. Mol. Med. pmid:20070436
Lee KJ et al. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. 2010 Biochim. Biophys. Acta pmid:20080132
Grabiec AM et al. Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. 2010 J. Immunol. pmid:20100935
Chatterjee A et al. An efficient synthesis of (+/-)-trichostatic Acid and analogues: a new route to (+/-)-trichostatin A. 2010 Org. Lett. pmid:20104892
Kicic A et al. Decreased fibronectin production significantly contributes to dysregulated repair of asthmatic epithelium. 2010 Am. J. Respir. Crit. Care Med. pmid:20110557
Su Y et al. Human RecQL4 helicase plays critical roles in prostate carcinogenesis. 2010 Cancer Res. pmid:21045146
Taura A et al. Histone deacetylase inhibition enhances adenoviral vector transduction in inner ear tissue. 2010 Neuroscience pmid:20060033
Chou JL et al. Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. 2010 Lab. Invest. pmid:20065949
Giles KE et al. Chromatin boundaries, insulators, and long-range interactions in the nucleus. 2010 Cold Spring Harb. Symp. Quant. Biol. pmid:21047907
Chang J et al. Hepatopoietin Cn suppresses apoptosis of human hepatocellular carcinoma cells by up-regulating myeloid cell leukemia-1. 2010 World J. Gastroenterol. pmid:20066738
Huber K et al. Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins). 2010 J. Med. Chem. pmid:20030343
Kroening S et al. Characterization of connective tissue growth factor expression in primary cultures of human tubular epithelial cells: modulation by hypoxia. 2010 Am. J. Physiol. Renal Physiol. pmid:20032117
Bracha AL et al. Carbon metabolism-mediated myogenic differentiation. 2010 Nat. Chem. Biol. pmid:20081855
Pan L et al. Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A /sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation. 2010 FEBS J. pmid:20089040
Bayles R et al. Histone modifications regulate the norepinephrine transporter gene. 2010 Cell Cycle pmid:21088495
Wang J et al. Effect of EGF-induced HDAC6 activation on corneal epithelial wound healing. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20089874
Li Y et al. Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells. 2010 Mol. Cancer pmid:20946668
Gupta PK et al. Inhibitors selective for HDAC6 in enzymes and cells. 2010 Bioorg. Med. Chem. Lett. pmid:20947351
Meng CF et al. Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells. 2010 Cancer Invest. pmid:19857042
Sayan BS et al. Induction of TAp63 by histone deacetylase inhibitors. 2010 Biochem. Biophys. Res. Commun. pmid:20043870
Shiau RJ et al. Genistein and beta-carotene enhance the growth-inhibitory effect of trichostatin A in A549 cells. 2010 Eur J Nutr pmid:19639378
Karagiannis TC et al. Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes. 2010 Aging (Albany NY) pmid:20930262
Reichrath S et al. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines. 2010 J. Steroid Biochem. Mol. Biol. pmid:20206691
Milagre I et al. Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination. 2010 J. Alzheimers Dis. pmid:20930312
Bertrand P Inside HDAC with HDAC inhibitors. 2010 Eur J Med Chem pmid:20223566
Gao A et al. Methylation of PARP-1 promoter involved in the regulation of benzene-induced decrease of PARP-1 mRNA expression. 2010 Toxicol. Lett. pmid:20230882
Majid S et al. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. 2010 Cancer Res. pmid:20332239
Khobta A et al. Gene silencing induced by oxidative DNA base damage: association with local decrease of histone H4 acetylation in the promoter region. 2010 Nucleic Acids Res. pmid:20338881
Kim SH et al. Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein. 2010 Breast Cancer Res. pmid:20388208
Kongruttanachok N et al. Replication independent DNA double-strand break retention may prevent genomic instability. 2010 Mol. Cancer pmid:20356374
Terracciano S et al. Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222. 2010 Bioorg. Med. Chem. pmid:20381359
Zhang LX et al. Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition. 2010 Am. J. Physiol. Heart Circ. Physiol. pmid:20382965
Pan L et al. HDAC4 inhibits the transcriptional activation of mda-7/IL-24 induced by Sp1. 2010 Cell. Mol. Immunol. pmid:20383178
Kim HB et al. Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors. 2010 Mol. Cell. Biol. pmid:20385772
Varma A and Kwon-Chung KJ Heteroresistance of Cryptococcus gattii to fluconazole. 2010 Antimicrob. Agents Chemother. pmid:20385871
Yang H et al. Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells. 2010 Exp. Biol. Med. (Maywood) pmid:20404016
Sponziello M et al. Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines. 2010 J. Endocrinol. Invest. pmid:19794300
Himaki T et al. Effects of trichostatin A on in vitro development and transgene function in somatic cell nuclear transfer embryos derived from transgenic Clawn miniature pig cells. 2010 Anim. Sci. J. pmid:20887307
Wu P et al. Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells. 2010 Cell Death Differ. pmid:19798105
Peidis P et al. HDAC pharmacological inhibition promotes cell death through the eIF2α kinases PKR and GCN2. 2010 Aging (Albany NY) pmid:21076179
Di Renzo F et al. VPA-related axial skeletal defects and apoptosis: a proposed event cascade. 2010 Reprod. Toxicol. pmid:19850124
Patil V et al. Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group. 2010 Bioorg. Med. Chem. pmid:19914074
Choi JH et al. TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116. 2010 Biochem. Biophys. Res. Commun. pmid:19914212
Dong G et al. Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells. 2010 Am. J. Physiol. Renal Physiol. pmid:19889954
Bhuiyan MM et al. Production of Sei whale (Balaenoptera borealis) cloned embryos by inter- and intra-species somatic cell nuclear transfer. 2010 J. Reprod. Dev. pmid:19893277
Ellis JK et al. Effect of the histone deacetylase inhibitor trichostatin a on the metabolome of cultured primary hepatocytes. 2010 J. Proteome Res. pmid:19894772
Wang N and Tilly JL Epigenetic status determines germ cell meiotic commitment in embryonic and postnatal mammalian gonads. 2010 Cell Cycle pmid:20009537
Wang L et al. Chronic cocaine-induced H3 acetylation and transcriptional activation of CaMKIIalpha in the nucleus accumbens is critical for motivation for drug reinforcement. 2010 Neuropsychopharmacology pmid:20010550
Estiu G et al. On the inhibition of histone deacetylase 8. 2010 Bioorg. Med. Chem. pmid:20472442
Kobori A et al. Butyrate stimulates IL-32alpha expression in human intestinal epithelial cell lines. 2010 World J. Gastroenterol. pmid:20480520
Kiyokawa S et al. New orally bioavailable 2-aminobenzamide-type histone deacetylase inhibitor possessing a (2-hydroxyethyl)(4-(thiophen-2-yl)benzyl)amino group. 2010 Bioorg. Med. Chem. pmid:20452226
Barua S and Rege K The influence of mediators of intracellular trafficking on transgene expression efficacy of polymer-plasmid DNA complexes. 2010 Biomaterials pmid:20452664
Marshall H et al. Deficiency of the dual ubiquitin/SUMO ligase Topors results in genetic instability and an increased rate of malignancy in mice. 2010 BMC Mol. Biol. pmid:20429939
Zhao TC et al. gp-91 mediates histone deacetylase inhibition-induced cardioprotection. 2010 Biochim. Biophys. Acta pmid:20433879
Jeon HW and Lee YM Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression. 2010 Mol. Cancer Ther. pmid:20442303